<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:721272a1-28f6-479d-8921-55bf3792b729,g:e6e63eaa-4a73-42e1-87eb-dda12e114757-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CoverPage" xlink:type="simple" xlink:href="anab-20200930.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="anab-20200930.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6956e7fe-3270-4b1b-aa06-4beea8f8a56f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cae4d810-c543-41a5-bd57-5801ecc09de4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6956e7fe-3270-4b1b-aa06-4beea8f8a56f" xlink:to="loc_us-gaap_AssetsCurrent_cae4d810-c543-41a5-bd57-5801ecc09de4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8b9e0d03-cc36-4035-ae01-e1a8eeda3d7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6956e7fe-3270-4b1b-aa06-4beea8f8a56f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8b9e0d03-cc36-4035-ae01-e1a8eeda3d7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_0820cbd8-b02e-49b8-bc29-7eee5b5c8505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6956e7fe-3270-4b1b-aa06-4beea8f8a56f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_0820cbd8-b02e-49b8-bc29-7eee5b5c8505" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0fe4988a-7e18-40a9-95f3-9773aca6a020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6956e7fe-3270-4b1b-aa06-4beea8f8a56f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0fe4988a-7e18-40a9-95f3-9773aca6a020" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1ffeb006-7d20-4fdd-88d7-c04e95ce6315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6956e7fe-3270-4b1b-aa06-4beea8f8a56f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1ffeb006-7d20-4fdd-88d7-c04e95ce6315" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4845b992-45ce-4e2e-89cf-721bdd7977ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_65eea326-1b85-4f50-b1ad-f1befcaf98c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4845b992-45ce-4e2e-89cf-721bdd7977ae" xlink:to="loc_us-gaap_LiabilitiesCurrent_65eea326-1b85-4f50-b1ad-f1befcaf98c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d4542b53-7873-4f55-8a79-7be42264d87d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4845b992-45ce-4e2e-89cf-721bdd7977ae" xlink:to="loc_us-gaap_StockholdersEquity_d4542b53-7873-4f55-8a79-7be42264d87d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7c677204-1a21-41b4-b712-083065190b93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4845b992-45ce-4e2e-89cf-721bdd7977ae" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7c677204-1a21-41b4-b712-083065190b93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_294a3ed2-94e5-47e6-b48b-05609069a33e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_494f35c7-8485-4e7f-b7fd-aed7b91cd0e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_294a3ed2-94e5-47e6-b48b-05609069a33e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_494f35c7-8485-4e7f-b7fd-aed7b91cd0e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2bbd50e6-31b3-4711-afa6-4df66d840fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_294a3ed2-94e5-47e6-b48b-05609069a33e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_2bbd50e6-31b3-4711-afa6-4df66d840fd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0c5fd101-2dd1-4b7e-8a68-c8bbd72de6ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_294a3ed2-94e5-47e6-b48b-05609069a33e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0c5fd101-2dd1-4b7e-8a68-c8bbd72de6ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ca86beac-bc85-4215-9359-79920ab4f4c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8b21fc8a-f7eb-4948-b004-4ffe3040903f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ca86beac-bc85-4215-9359-79920ab4f4c8" xlink:to="loc_us-gaap_CommonStockValue_8b21fc8a-f7eb-4948-b004-4ffe3040903f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_02c165ba-1358-4483-aa47-e5dc1d0d3424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ca86beac-bc85-4215-9359-79920ab4f4c8" xlink:to="loc_us-gaap_AdditionalPaidInCapital_02c165ba-1358-4483-aa47-e5dc1d0d3424" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e176a5cf-a5a3-4e70-a0bf-a7fd9f283ea7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ca86beac-bc85-4215-9359-79920ab4f4c8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e176a5cf-a5a3-4e70-a0bf-a7fd9f283ea7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b0731329-ee08-4f8f-8d26-a1c807157cd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ca86beac-bc85-4215-9359-79920ab4f4c8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b0731329-ee08-4f8f-8d26-a1c807157cd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_842abd74-adb0-4240-9329-6457ca05cd0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ca86beac-bc85-4215-9359-79920ab4f4c8" xlink:to="loc_us-gaap_PreferredStockValue_842abd74-adb0-4240-9329-6457ca05cd0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9f1e08dc-9fa7-450a-ad66-45f865ba4dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_4b2c6ced-17ca-439f-a50d-0ccbf484a0f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9f1e08dc-9fa7-450a-ad66-45f865ba4dfd" xlink:to="loc_us-gaap_AccountsPayableCurrent_4b2c6ced-17ca-439f-a50d-0ccbf484a0f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_1e4d8d42-95cc-4f61-b3a4-47796440f9d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9f1e08dc-9fa7-450a-ad66-45f865ba4dfd" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_1e4d8d42-95cc-4f61-b3a4-47796440f9d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_f1fd7118-c2af-4258-bdad-c3502749dcff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9f1e08dc-9fa7-450a-ad66-45f865ba4dfd" xlink:to="loc_us-gaap_NotesPayableCurrent_f1fd7118-c2af-4258-bdad-c3502749dcff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_de840ad3-c76f-4872-9673-65ea8f50313a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9f1e08dc-9fa7-450a-ad66-45f865ba4dfd" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_de840ad3-c76f-4872-9673-65ea8f50313a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="anab-20200930.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="anab-20200930.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_086398db-92de-4e3a-9e2a-710a8377e8ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_4dce63dd-0076-48e9-8b2c-fc19a8b64919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_086398db-92de-4e3a-9e2a-710a8377e8ca" xlink:to="loc_us-gaap_OperatingExpenses_4dce63dd-0076-48e9-8b2c-fc19a8b64919" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b63f9dd6-8f2d-4bbd-b06f-252eced214d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_086398db-92de-4e3a-9e2a-710a8377e8ca" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b63f9dd6-8f2d-4bbd-b06f-252eced214d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_eb8e62d6-10e2-4d11-b1e1-d02b0e340585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d8b292be-0a89-4ddc-a007-e9668d2f8b3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_eb8e62d6-10e2-4d11-b1e1-d02b0e340585" xlink:to="loc_us-gaap_InterestExpense_d8b292be-0a89-4ddc-a007-e9668d2f8b3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a0b73bce-8847-4b2d-b205-164dcc6bb04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_eb8e62d6-10e2-4d11-b1e1-d02b0e340585" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a0b73bce-8847-4b2d-b205-164dcc6bb04f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6eb6133d-e9ff-4343-9b23-9b5139306ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_eb8e62d6-10e2-4d11-b1e1-d02b0e340585" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6eb6133d-e9ff-4343-9b23-9b5139306ac6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_34d274b3-07d2-4e61-9c36-124aa1eee491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d3b0fc84-3fb7-46a2-94cf-9c3a000d9543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_34d274b3-07d2-4e61-9c36-124aa1eee491" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d3b0fc84-3fb7-46a2-94cf-9c3a000d9543" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ef02eb7a-c34a-49b2-97fb-cad23f48e2fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_34d274b3-07d2-4e61-9c36-124aa1eee491" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ef02eb7a-c34a-49b2-97fb-cad23f48e2fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5921583b-7d39-466b-a25a-70dfa28ae6e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_cc083492-8479-48dc-87b7-10dca506bfaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5921583b-7d39-466b-a25a-70dfa28ae6e2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_cc083492-8479-48dc-87b7-10dca506bfaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_44229cef-2d0d-4bf8-a585-90e33164f0ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5921583b-7d39-466b-a25a-70dfa28ae6e2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_44229cef-2d0d-4bf8-a585-90e33164f0ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6dc4b66c-b2e7-445e-9cfb-54398e981d0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2b9a1d27-02e2-42e3-b7b0-bde6fb6d7812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6dc4b66c-b2e7-445e-9cfb-54398e981d0a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2b9a1d27-02e2-42e3-b7b0-bde6fb6d7812" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bb747f35-d7b9-462c-a80d-a09858f7a34f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6dc4b66c-b2e7-445e-9cfb-54398e981d0a" xlink:to="loc_us-gaap_OperatingIncomeLoss_bb747f35-d7b9-462c-a80d-a09858f7a34f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_843be62b-05c4-47d5-ba71-af3e42820d5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3b7092ee-ea3e-4266-8d5f-599d7653541e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_843be62b-05c4-47d5-ba71-af3e42820d5c" xlink:to="loc_us-gaap_NetIncomeLoss_3b7092ee-ea3e-4266-8d5f-599d7653541e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_b55315f4-a8e8-4b7e-b0c8-a07b7d33a59a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_843be62b-05c4-47d5-ba71-af3e42820d5c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_b55315f4-a8e8-4b7e-b0c8-a07b7d33a59a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/ConsolidatedStatementsofOperationsandComprehensiveLossParenthetical" xlink:type="simple" xlink:href="anab-20200930.xsd#ConsolidatedStatementsofOperationsandComprehensiveLossParenthetical"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/ConsolidatedStatementsofOperationsandComprehensiveLossParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/ConsolidatedStatementofStockholdersEquity" xlink:type="simple" xlink:href="anab-20200930.xsd#ConsolidatedStatementofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/ConsolidatedStatementofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="anab-20200930.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3f1073ab-5a07-419f-842c-c973e271a14f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_55d24aaf-4e0b-4425-bb10-e19d8b4a167e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3f1073ab-5a07-419f-842c-c973e271a14f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_55d24aaf-4e0b-4425-bb10-e19d8b4a167e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8aba2362-9a1a-42dd-872d-c517b51bc647" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3f1073ab-5a07-419f-842c-c973e271a14f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8aba2362-9a1a-42dd-872d-c517b51bc647" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5cc07f5e-7b4b-46a7-bd04-2438a8b5231e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3f1073ab-5a07-419f-842c-c973e271a14f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5cc07f5e-7b4b-46a7-bd04-2438a8b5231e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2fb617b-7049-4c29-bc18-2e7deed721ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_4199cbff-0500-45ae-941d-878c1a91e681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2fb617b-7049-4c29-bc18-2e7deed721ee" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_4199cbff-0500-45ae-941d-878c1a91e681" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_b7e03451-b8d5-462f-a41b-1782a9e3b49c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2fb617b-7049-4c29-bc18-2e7deed721ee" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_b7e03451-b8d5-462f-a41b-1782a9e3b49c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0b8073c6-dba8-4b87-b9ba-dd79e37eb3a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_46e73a27-55f9-4f37-8be0-9b26c0c452f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0b8073c6-dba8-4b87-b9ba-dd79e37eb3a8" xlink:to="loc_us-gaap_NetIncomeLoss_46e73a27-55f9-4f37-8be0-9b26c0c452f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c6ca0c68-0dc1-4ccd-aba0-76331f23d571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0b8073c6-dba8-4b87-b9ba-dd79e37eb3a8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c6ca0c68-0dc1-4ccd-aba0-76331f23d571" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_SharebasedCompensationAndIssuanceOfStockAndWarrantsForServicesOrClaims_203454eb-2348-4466-b27d-27f5cb0bdb8c" xlink:href="anab-20200930.xsd#anab_SharebasedCompensationAndIssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0b8073c6-dba8-4b87-b9ba-dd79e37eb3a8" xlink:to="loc_anab_SharebasedCompensationAndIssuanceOfStockAndWarrantsForServicesOrClaims_203454eb-2348-4466-b27d-27f5cb0bdb8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_faa8b603-78c1-46d3-8c27-06318621fe95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0b8073c6-dba8-4b87-b9ba-dd79e37eb3a8" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_faa8b603-78c1-46d3-8c27-06318621fe95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_64eda904-000a-492a-9420-7403df56c7fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0b8073c6-dba8-4b87-b9ba-dd79e37eb3a8" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_64eda904-000a-492a-9420-7403df56c7fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6be71696-fa28-46cc-804d-bdef1a9fdb74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0b8073c6-dba8-4b87-b9ba-dd79e37eb3a8" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6be71696-fa28-46cc-804d-bdef1a9fdb74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_bac164a6-0520-428e-86cc-8dae677ea268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0b8073c6-dba8-4b87-b9ba-dd79e37eb3a8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_bac164a6-0520-428e-86cc-8dae677ea268" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c88267c5-3a52-4720-a251-51c39b04d168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_c27d51d5-032c-4cee-9e6f-41b6c87971ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c88267c5-3a52-4720-a251-51c39b04d168" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_c27d51d5-032c-4cee-9e6f-41b6c87971ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_9c0a190b-26d5-437b-b9ba-429b8c4af980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c88267c5-3a52-4720-a251-51c39b04d168" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_9c0a190b-26d5-437b-b9ba-429b8c4af980" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_98d23865-49a6-4d6e-af5e-551197fce7e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c88267c5-3a52-4720-a251-51c39b04d168" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_98d23865-49a6-4d6e-af5e-551197fce7e5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/DescriptionoftheBusiness" xlink:type="simple" xlink:href="anab-20200930.xsd#DescriptionoftheBusiness"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/DescriptionoftheBusiness" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="anab-20200930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="anab-20200930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="anab-20200930.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesSummaryofPotentiallyDilutiveSecuritiesDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#SummaryofSignificantAccountingPoliciesSummaryofPotentiallyDilutiveSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/SummaryofSignificantAccountingPoliciesSummaryofPotentiallyDilutiveSecuritiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosures" xlink:type="simple" xlink:href="anab-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosures"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosures" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables" xlink:type="simple" xlink:href="anab-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosuresTables"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresPropertyandEquipmentDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosuresPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cab8997b-e1bd-4495-9af4-4272fd7cabd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_3482b413-50f6-49f1-937c-90642d8f8d8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_cab8997b-e1bd-4495-9af4-4272fd7cabd5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_3482b413-50f6-49f1-937c-90642d8f8d8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0c315188-d2cc-4be8-95ba-c82096b7be17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_cab8997b-e1bd-4495-9af4-4272fd7cabd5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0c315188-d2cc-4be8-95ba-c82096b7be17" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresAccruedExpensesDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosuresAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_b806680d-9b9f-4d45-a2aa-3c764783bf0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_44a56a99-d9e5-45ad-955f-a11a5387fbb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b806680d-9b9f-4d45-a2aa-3c764783bf0a" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_44a56a99-d9e5-45ad-955f-a11a5387fbb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_c9770470-aa87-4092-aab5-343b0c416bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b806680d-9b9f-4d45-a2aa-3c764783bf0a" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_c9770470-aa87-4092-aab5-343b0c416bd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_AccruedResearchAndDevelopmentExpensesCurrent_abc3a946-c675-4d4d-8472-355f3e422a8b" xlink:href="anab-20200930.xsd#anab_AccruedResearchAndDevelopmentExpensesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b806680d-9b9f-4d45-a2aa-3c764783bf0a" xlink:to="loc_anab_AccruedResearchAndDevelopmentExpensesCurrent_abc3a946-c675-4d4d-8472-355f3e422a8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3bfeedd2-3905-4d72-8ff7-41aa69a7f21c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b806680d-9b9f-4d45-a2aa-3c764783bf0a" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3bfeedd2-3905-4d72-8ff7-41aa69a7f21c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreements" xlink:type="simple" xlink:href="anab-20200930.xsd#CollaborativeResearchandDevelopmentAgreements"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreementsTables" xlink:type="simple" xlink:href="anab-20200930.xsd#CollaborativeResearchandDevelopmentAgreementsTables"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreementsDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#CollaborativeResearchandDevelopmentAgreementsDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/CollaborativeResearchandDevelopmentAgreementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/NotesPayable" xlink:type="simple" xlink:href="anab-20200930.xsd#NotesPayable"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/NotesPayable" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/NotesPayableDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#NotesPayableDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/NotesPayableDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments" xlink:type="simple" xlink:href="anab-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestments"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables" xlink:type="simple" xlink:href="anab-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsTables"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsFairValueofOtherFinancialInstrumentsDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsFairValueofOtherFinancialInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsFairValueofOtherFinancialInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAvailableforsaleInvestmentsDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsAvailableforsaleInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAvailableforsaleInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8db51d1d-9eb6-4e46-907a-8844dc76d397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0c3e64b8-97a8-4432-80ae-2005206762a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8db51d1d-9eb6-4e46-907a-8844dc76d397" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0c3e64b8-97a8-4432-80ae-2005206762a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_71fa6406-c96d-4311-9633-f75f241590fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8db51d1d-9eb6-4e46-907a-8844dc76d397" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_71fa6406-c96d-4311-9633-f75f241590fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_58f483ed-1d63-4e17-a9f8-7ff392cbcc12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8db51d1d-9eb6-4e46-907a-8844dc76d397" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_58f483ed-1d63-4e17-a9f8-7ff392cbcc12" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofUnrealizedLossandFairValuesinaLossPositionDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofUnrealizedLossandFairValuesinaLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofUnrealizedLossandFairValuesinaLossPositionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/StockholdersEquity" xlink:type="simple" xlink:href="anab-20200930.xsd#StockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/StockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="anab-20200930.xsd#StockholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/StockholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/StockholdersEquitySummaryofCommonStockReservedforFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_6268fab1-9195-4e59-ba2c-42a46a5cc203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30fc57a0-271e-4dd3-94a6-384f2d0fd121" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_6268fab1-9195-4e59-ba2c-42a46a5cc203" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30fc57a0-271e-4dd3-94a6-384f2d0fd121" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b3d260cb-8d5e-4ec4-89cf-70d90732c1f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_6268fab1-9195-4e59-ba2c-42a46a5cc203" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b3d260cb-8d5e-4ec4-89cf-70d90732c1f2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/EquityIncentivePlans" xlink:type="simple" xlink:href="anab-20200930.xsd#EquityIncentivePlans"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/EquityIncentivePlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/EquityIncentivePlansTables" xlink:type="simple" xlink:href="anab-20200930.xsd#EquityIncentivePlansTables"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/EquityIncentivePlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/EquityIncentivePlansNarrativeDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#EquityIncentivePlansNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/EquityIncentivePlansNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/EquityIncentivePlansOptionActivityDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#EquityIncentivePlansOptionActivityDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/EquityIncentivePlansOptionActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/EquityIncentivePlansOptionFairValueAssumptionsDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#EquityIncentivePlansOptionFairValueAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/EquityIncentivePlansOptionFairValueAssumptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/EquityIncentivePlansAllocationofSharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#EquityIncentivePlansAllocationofSharebasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/EquityIncentivePlansAllocationofSharebasedCompensationExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="anab-20200930.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="anab-20200930.xsd#CommitmentsandContingenciesTables"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/CommitmentsandContingenciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CommitmentsandContingenciesClassificationontheBalanceSheetDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#CommitmentsandContingenciesClassificationontheBalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/CommitmentsandContingenciesClassificationontheBalanceSheetDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CommitmentsandContingenciesCostsIncludedinCashFlowStatementDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#CommitmentsandContingenciesCostsIncludedinCashFlowStatementDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/CommitmentsandContingenciesCostsIncludedinCashFlowStatementDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CommitmentsandContingenciesScheduleofFutureMinimumAnnualObligationsDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#CommitmentsandContingenciesScheduleofFutureMinimumAnnualObligationsDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/CommitmentsandContingenciesScheduleofFutureMinimumAnnualObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fff105ea-1d04-4492-9ae5-69f37be0556a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_33a4baaf-b064-4ac0-87e4-d9729b302c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fff105ea-1d04-4492-9ae5-69f37be0556a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_33a4baaf-b064-4ac0-87e4-d9729b302c7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_9f60c5d7-8e1f-4bef-8d25-9337f7fa492f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fff105ea-1d04-4492-9ae5-69f37be0556a" xlink:to="loc_us-gaap_OperatingLeaseLiability_9f60c5d7-8e1f-4bef-8d25-9337f7fa492f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/CommitmentsandContingenciesScheduleofFutureMinimumAnnualObligationsDetails_1" xlink:type="simple" xlink:href="anab-20200930.xsd#CommitmentsandContingenciesScheduleofFutureMinimumAnnualObligationsDetails_1"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/CommitmentsandContingenciesScheduleofFutureMinimumAnnualObligationsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_825060eb-96dd-40b3-b6af-6e84db1cef9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_2930fa80-831a-4d49-b07a-467079fd426f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_825060eb-96dd-40b3-b6af-6e84db1cef9b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_2930fa80-831a-4d49-b07a-467079fd426f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_cddcf878-5ff1-4645-bec6-fc30811720ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_825060eb-96dd-40b3-b6af-6e84db1cef9b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_cddcf878-5ff1-4645-bec6-fc30811720ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2faefc61-3f99-45df-a49e-1aa460cf3684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_825060eb-96dd-40b3-b6af-6e84db1cef9b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2faefc61-3f99-45df-a49e-1aa460cf3684" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_53f8afd4-46f4-4c02-8981-4e91e9eed510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_825060eb-96dd-40b3-b6af-6e84db1cef9b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_53f8afd4-46f4-4c02-8981-4e91e9eed510" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0f038ccc-146a-47e2-991d-fb4713f20867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_825060eb-96dd-40b3-b6af-6e84db1cef9b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0f038ccc-146a-47e2-991d-fb4713f20867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_anab_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_4a5c5c2f-3064-4b3d-bef7-03457bc94349" xlink:href="anab-20200930.xsd#anab_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_825060eb-96dd-40b3-b6af-6e84db1cef9b" xlink:to="loc_anab_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_4a5c5c2f-3064-4b3d-bef7-03457bc94349" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SubsequentEvents" xlink:type="simple" xlink:href="anab-20200930.xsd#SubsequentEvents"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/SubsequentEvents" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.anaptysbio.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="anab-20200930.xsd#SubsequentEventDetails"/>
  <link:calculationLink xlink:role="http://www.anaptysbio.com/role/SubsequentEventDetails" xlink:type="extended"/>
</link:linkbase>
